CX Institutional’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22K Buy
180
+56
+45% +$6.6K ﹤0.01% 1205
2026
Q2
$13K Buy
124
+1
+0.8% +$104 ﹤0.01% 1251
2026
Q1
$12K Buy
123
+109
+779% +$11.2K ﹤0.01% 1245
2025
Q4
$1K Buy
+14
New +$1.62K ﹤0.01% 1449
2022
Q3
– Sell
-15
Closed -$1K – 652
2022
Q2
$1K Buy
+15
New +$770 ﹤0.01% 1129

Other funds holding EHC

CX Institutional's EHC Position: Q3 2026 in Review

CX Institutional increased its Encompass Health (EHC) stake by 45% in Q3 2026, buying an estimated $6.6K and bringing the position to 180 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1205.

CX Institutional first reported a position in EHC in Q2 2022 and has held it in 5 quarters since. 117 funds tracked by Wall St. Rank hold EHC as of Q3 2026.

  • CX Institutional held 180 shares of Encompass Health worth $22K as of Q3 2026.
  • CX Institutional bought 56 Encompass Health shares in Q3 2026, an estimated $6.6K.
  • Encompass Health made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #1205 holding.
  • CX Institutional first reported a position in Encompass Health in Q2 2022 and has held it in 5 quarters since.
  • 117 funds tracked by Wall St. Rank held Encompass Health as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.